K. Antman

The crisis in clinical cancer research. Third-party insurance and investigational therapy.

E. Frei, L. Schnipper, K. Antman, 1988, The New England journal of medicine.

GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN

M. Socinski, S. Cannistra, A. Elias, 1988, The Lancet.

Reimbursement issues facing patients, providers, and payers

K. Antman, 1993, Cancer.

Enhancement of superoxide anion release by granulocytes harvested from patients receiving granulocyte‐macrophage colony‐stimulating factor

M. Socinski, J. Griffin, A. Elias, 1989, British journal of haematology.

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.

M. Socinski, S. Cannistra, J. Griffin, 1988, The New England journal of medicine.

Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation.

J. Fay, K. Sullivan, F. Appelbaum, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo.

M. Socinski, S. Cannistra, J. Griffin, 1988, Blood.